For adults the administration codes are: 90471: Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination ...

Introduction: The COVID-19 pandemic, driven by SARS-CoV-2, has made vaccination a critical strategy for global control.

PharmaJet and Scancell agreement builds on PharmaJet's strategy to be the best-in-class delivery system for novel DNA and RNA ...

A study conducted on the Intradermal, ID vaccine administration using the Tropis ID Needle-free Injection System, NFIS in Nigeria has shown that switching to needle-free delivered fIPV could save the ...

You should get 2 doses of the vaccine, at least 4 weeks apart. You can choose either subcutaneous or intradermal vaccination. If it has been more than 4 weeks since the first dose, the second dose can ...

Vaccine for Central Nervous System Cancer is under clinical development by Immunomic Therapeutics and currently in Phase I for Anaplastic Astrocytoma.

(“Ultimovacs”) (OSE ULTI), a clinical-stage biotechnology company developing novel immunotherapies against cancer, announces the presentation of updated data analysis from the UV1 Phase II NIPU trial ...

The section on "Route, site and technique for vaccine administration" was updated to expand on the administration of intradermal injections. This information is captured in the table of updates.

Here's what to know about the latest vaccines, who needs them and how they help prevent the more serious effects of COVID-19. The FDA granted emergency use authorization last week to an updated ...